These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32750408)
1. New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis. Tian S; Nakamura J; Hiller S; Simington S; Holley DW; Mota R; Willis MS; Bultman SJ; Luft JC; DeSimone JM; Jia Z; Maeda N; Yi X Vascul Pharmacol; 2020; 133-134():106777. PubMed ID: 32750408 [TBL] [Abstract][Full Text] [Related]
2. Reduced alpha-lipoic acid synthase gene expression exacerbates atherosclerosis in diabetic apolipoprotein E-deficient mice. Yi X; Xu L; Hiller S; Kim HS; Maeda N Atherosclerosis; 2012 Jul; 223(1):137-43. PubMed ID: 22658261 [TBL] [Abstract][Full Text] [Related]
3. Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice. Yi X; Xu L; Kim K; Kim HS; Maeda N Atherosclerosis; 2010 Aug; 211(2):424-30. PubMed ID: 20347443 [TBL] [Abstract][Full Text] [Related]
5. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4 Wan Q; Liu Z; Yang M; Wu J Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887 [TBL] [Abstract][Full Text] [Related]
6. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice. Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560 [TBL] [Abstract][Full Text] [Related]
7. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice. Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014 [TBL] [Abstract][Full Text] [Related]
8. Deletion of fibroblast activation protein provides atheroprotection. Stein S; Weber J; Nusser-Stein S; Pahla J; Zhang HE; Mohammed SA; Oppi S; Gaul DS; Paneni F; Tailleux A; Staels B; von Meyenn F; Ruschitzka F; Gorrell MD; Lüscher TF; Matter CM Cardiovasc Res; 2021 Mar; 117(4):1060-1069. PubMed ID: 32402085 [TBL] [Abstract][Full Text] [Related]
13. Regulatory CD4 Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316 [TBL] [Abstract][Full Text] [Related]
14. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice. Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071 [TBL] [Abstract][Full Text] [Related]
15. Impaired Autophagy in CD11b Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723 [TBL] [Abstract][Full Text] [Related]
16. Dietary rice protein isolate attenuates atherosclerosis in apoE-deficient mice by upregulating antioxidant enzymes. Burris RL; Xie CH; Thampi P; Wu X; Melnyk SB; Nagarajan S Atherosclerosis; 2010 Sep; 212(1):107-15. PubMed ID: 20839391 [TBL] [Abstract][Full Text] [Related]
17. Bee Venom Phospholipase A2 Ameliorates Atherosclerosis by Modulating Regulatory T Cells. Kang GH; Lee S; Choi DB; Shin D; Kim J; Yang H; Bae H Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32977607 [TBL] [Abstract][Full Text] [Related]